To provide high-quality, prompt, and cost-effective drug and device development services to its clients in the interest of delivering new therapeutics to those in need.

Clinilabs is a global, full-service contract research organization focused exclusively on CNS drug, device, and technology development. The Company partners with pharmaceutical, biotechnology, and medical device companies to provide a comprehensive spectrum of high-quality, timely, and cost-effective clinical drug development services from first-in-human to Phase 3 trials, all aimed at accelerating the availability of new CNS therapies in the market.